I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 13 studies | 27% ± 13% | |
| glutamatergic neuron | 7 studies | 40% ± 26% | |
| microglial cell | 7 studies | 27% ± 9% | |
| plasmacytoid dendritic cell | 7 studies | 20% ± 6% | |
| fibroblast | 7 studies | 22% ± 9% | |
| adipocyte | 7 studies | 23% ± 4% | |
| GABAergic neuron | 7 studies | 35% ± 20% | |
| astrocyte | 7 studies | 30% ± 11% | |
| oligodendrocyte | 7 studies | 24% ± 7% | |
| macrophage | 7 studies | 25% ± 6% | |
| natural killer cell | 6 studies | 19% ± 5% | |
| epithelial cell | 6 studies | 33% ± 11% | |
| B cell | 5 studies | 23% ± 6% | |
| dendritic cell | 5 studies | 29% ± 17% | |
| basal cell | 5 studies | 26% ± 11% | |
| interneuron | 5 studies | 36% ± 23% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 20% ± 4% | |
| neuron | 4 studies | 31% ± 8% | |
| myeloid cell | 4 studies | 22% ± 3% | |
| oligodendrocyte precursor cell | 4 studies | 33% ± 9% | |
| monocyte | 4 studies | 21% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 22% ± 5% | |
| CD8-positive, alpha-beta T cell | 3 studies | 21% ± 5% | |
| classical monocyte | 3 studies | 27% ± 6% | |
| hematopoietic precursor cell | 3 studies | 31% ± 14% | |
| non-classical monocyte | 3 studies | 29% ± 12% | |
| GABAergic interneuron | 3 studies | 17% ± 1% | |
| retina horizontal cell | 3 studies | 25% ± 1% | |
| ciliated cell | 3 studies | 25% ± 3% | |
| lymphocyte | 3 studies | 20% ± 3% | |
| club cell | 3 studies | 20% ± 4% | |
| alveolar macrophage | 3 studies | 22% ± 8% | |
| endothelial cell of lymphatic vessel | 3 studies | 22% ± 3% | |
| goblet cell | 3 studies | 29% ± 14% | |
| transit amplifying cell | 3 studies | 28% ± 16% | |
| mast cell | 3 studies | 20% ± 4% |
